Darek Fidyka's recovery described as 'more impressive than man walking on the Moon'
A fireman left paralysed in a stabbing attack has learnt to walk again after undergoing pioneering surgery using cells from his nose. Darek Fidyka, who is believed to be the first person in the world to recover from a completely severed spinal cord, said the experience of walking again was like being reborn. "It's an incredible feeling, difficult to describe," said the 40-year-old. "You're at a certain moment in your life when you think it will never happen again and yet... it's possible." About 1,000 people suffer a spinal cord injury each year in the UK and Ireland, and about 50,000 people are living with paralysis, says The Times. Patients with incomplete spinal injuries often recover, but until now complete spinal cord injuries have been broadly regarded as permanent and incurable. Fidyka, who was paralysed from wounds inflicted by his partner's ex-husband in July 2010, can now walk with a frame and even drive a car. "Spinal cord injury is quite easy to do and utterly devastating for the people who have it," said Geoffrey Raisman, of University College London, who pioneered the technique. "This opens a door that was not open before. I think we're looking at something historic." He described Fidyka's recovery as "more impressive than man walking on the Moon". Scientists in Poland transplanted "olfactory ensheathing" cells (OECs) from his nose to his spine, enabling the ends of severed nerve fibres to grow and join together – a process that was previously believed to be impossible, says the Daily Mail. Raisman compared the technique to motorists finding other routes around a closed section of motorway, adding: "What we're doing is repairing the motorway." The research was funded by the UK Stem Cell Foundation and Nicholls Spinal Injury Foundation, founded by the British hotelier David Nicholls, whose son Daniel was paralysed in a swimming accident at the age of 18. Scientists are now planning to treat ten more paralysed patients in a carefully controlled clinical trial. For further concise, balanced comment and analysis on the week's news, try The Week magazine. Subscribe today and get 6 issues completely free. Source: The Week UK
